Short answer · Medically reviewed summary · Last updated: 2026-05-08
Neonatal Hemochromatosis (NH) is most accurately referred to today as Gestational Alloimmune Liver Disease (GALD), reflecting the current understanding that the condition is driven by maternal alloantibodies. While historically called Neonatal Hemochromatosis due to the iron overload observed in the liver, medical professionals now prefer the GALD terminology to better describe the underlying immune-mediated pathophysiology. What are the historical and alternative names for Neonatal Hemochromatosis? In older medical literature and some international clinical settings, Neonatal Hemochromatosis may still be referred to by several names.
Neonatal Hemochromatosis synonyms
Other names for Neonatal Hemochromatosis: synonyms, acronyms and related terms used by doctors and patients.
Neonatal Hemochromatosis (NH) is most accurately referred to today as Gestational Alloimmune Liver Disease (GALD), reflecting the current understanding that the condition is driven by maternal alloantibodies. While historically called Neonatal Hemochromatosis due to the iron overload observed in the liver, medical professionals now prefer the GALD terminology to better describe the underlying immune-mediated pathophysiology.
What are the historical and alternative names for Neonatal Hemochromatosis?
In older medical literature and some international clinical settings, Neonatal Hemochromatosis may still be referred to by several names. These include:
- Gestational Alloimmune Liver Disease (GALD): The currently preferred clinical term.
- Neonatal Iron Storage Disease: A descriptive term emphasizing the iron accumulation.
- Severe Neonatal Liver Failure: A clinical description used before the specific cause was identified.
- Alloimmune Liver Disease of the Newborn: A name that highlights the immune mechanism.
Why has the name of the condition changed?
The transition from the name Neonatal Hemochromatosis to Gestational Alloimmune Liver Disease represents a major shift in medical understanding. Historically, the disease was named for the iron overload found in the liver, which was thought to be a primary metabolic defect. Research now confirms that Neonatal Hemochromatosis is actually an alloimmune process where maternal antibodies attack the fetal liver. Using the term GALD helps clinicians focus on the correct treatment, which involves IVIG (intravenous immunoglobulin) and exchange transfusions to halt the antibody damage.
How is the condition classified in medical databases?
Major medical databases provide standardized codes to help navigate these nomenclature changes:
- Orphanet: Classified under ORPHA:280456.
- OMIM: Listed as Neonatal Hemochromatosis under #231100.
- ICD-10/11: Often coded under general neonatal liver failure or specific iron metabolism disorders, though clinicians are increasingly documenting it as GALD.
Next steps
- Consult a pediatric hepatologist or a specialist in neonatal alloimmune conditions to ensure your records reflect the most recent diagnostic understanding.
- Connect with the 42 members of the Neonatal Hemochromatosis community at DiseaseMaps.org to share experiences regarding diagnosis and treatment journeys.
- Request genetic counseling if you are planning future pregnancies, as Neonatal Hemochromatosis (GALD) has a high recurrence risk in subsequent gestations.
Medical disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment.
References
- Orphanet: Gestational alloimmune liver disease (ORPHA:280456)
- NIH GARD: Neonatal hemochromatosis information page
- OMIM: Neonatal hemochromatosis (Entry #231100)
- PubMed: Clinical reviews on the pathophysiology of GALD/Neonatal Hemochromatosis
